Liquid biopsy cancer screening: We’ll need more than one size to fit all

Pasi Jänne receives 2024 Bonnie J. Addario Lectureship Award

Pasi A. Jänne received the GO2 for Lung Cancer’s 2024 Bonnie J. Addario Lectureship Award.

August 02, 2024

Vaping and smoking together increases lung cancer risk fourfold

People who both vape and smoke are four times more likely to develop lung cancer than people who just smoke, according to a new study published by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and College of Public Health.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

OncoHost, a technology company, announced the publication of a study in Clinical Lung Cancer demonstrating the impact of its PROphetNSCLC test on first-line treatment decisions for metastatic non-small cell lung cancer patients.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Neighborhood violence may influence tumor biology, worsening lung cancer outcomes

Scientists have identified a potential driver of aggressive lung cancer tumors in patients who live in areas with high levels of violent crime. Their study found that stress responses differ between those living in neighborhoods with higher and lower levels of violent crime, and between cancerous and healthy tissues in the same individuals.

July 26, 2024

Vol.50 No.30

Clinical Roundup

Novel liquid biopsy methodology can track evolution of metastatic prostate cancer

DNA/RNA material contained in circulating extracellular vesicles secreted into the bloodstream by tumor cells captures cancer genomics and transcriptomic evolution in patients with metastatic prostate cancer, according to a new study.

July 26, 2024

Vol.50 No.30

Clinical Roundup

Screenings overlook hereditary genetic risk for some cancers

Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer syndrome and Lynch syndrome, which increase the risk of developing certain cancers. This issue is particularly pronounced among underrepresented minorities.

July 19, 2024

Vol.50 No.29

Liquid biopsy cancer screening: We’ll need more than one size to fit all

YOU MAY BE INTERESTED IN

Pasi Jänne receives 2024 Bonnie J. Addario Lectureship Award

Vaping and smoking together increases lung cancer risk fourfold

Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

Neighborhood violence may influence tumor biology, worsening lung cancer outcomes

Novel liquid biopsy methodology can track evolution of metastatic prostate cancer

Screenings overlook hereditary genetic risk for some cancers

Renew today!

Subscriber content

Login